Portal de investigación
- Inicio /
- Proyectos y Estudios /
- ENSAYO OPTIMIZADO EN FASE III DE INMUNOESTIMULACIÓN CON MARAVIROC, UN ANTAGONISTA DEL CCR5, COMBINADO CON TERAPIA ANTIRRETROVIRAL (CTAR) EN PACIENTES CON INFECCIÓN AVANZADA POR EL VIH-1, DIAGNOSTICADOS TARDÍAMENTE, CON UN ACONTECIMIENTO DEFINITORIO DE SIDA Y/O RECUENTOS DE CD4 INFERIORES A 200 CÉLULAS/MM3.
ENSAYO OPTIMIZADO EN FASE III DE INMUNOESTIMULACIÓN CON MARAVIROC, UN ANTAGONISTA DEL CCR5, COMBINADO CON TERAPIA ANTIRRETROVIRAL (CTAR) EN PACIENTES CON INFECCIÓN AVANZADA POR EL VIH-1, DIAGNOSTICADOS TARDÍAMENTE, CON UN ACONTECIMIENTO DEFINITORIO DE SIDA Y/O RECUENTOS DE CD4 INFERIORES A 200 CÉLULAS/MM3.
Datos básicos
- Protocolo:
- ANRS146OPTIMAL
- EUDRACT:
- 2010-022293-14
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2013
- Año de finalización:
- 2016
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO
Documentos
- No hay documentos
Participantes
-
Marta Montero Alonso
Investigador Principal
Grupos
-
Investigacion clínica en enfermedades crónicas e Infección por el VIH
Investigador establecido
Marta Montero Alonso
Financiadores - Promotores
Resultados del Ensayo Clínico
[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].
Polo Rodríguez R; (...); Martínez Chamorro E
Abstract of Published Item. 10.1016/j.eimc.2014.06.006. 2015
[Epidemiology and prevention of nosocomial invasive infections by filamentous fungi and yeasts].
Abstract of Published Item. 10.1016/j.eimc.2013.02.002. 2013
[Farewell open letter to SEFH members].
Editorial Material. 10.7399/fh.2015.39.6.10128. 2015
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.
Cuervo G; (...); Validation Cohort Project
Article. 10.1016/j.cmi.2015.02.029. 2015
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Article. 10.1038/tpj.2015.80. 2016
Aflibercept in exudative age related macular degeneration refractory to ranibizumab.
Ruiz Ramos J; (...); Gallego-Pinazo R
Article. 10.1016/j.oftal.2015.07.018. 2015
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Assessment of the quality of sample labelling for clinical research.
Pérez-Huertas P; (...); Poveda-Andrés JL
Article. 10.7399/fh.2016.40.2.9753. 2016
Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients
Aldámiz-Echevarría T; (...); Berenguer J
Article. 10.1016/S1665-2681(19)31167-6. 2015
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Bacteraemia and infection of the vascular catheter in the haematology patient: positioning and management based on the Delphi method
Azanza-Perea, JR; (...); Rivas-Gonzalez, P
Article. 2016
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen
Article. 10.1016/j.bbmt.2014.12.038. 2015
Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting
Di Benedetto N; (...); Salavert M
Article. 2015
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma
Blanes M; (...); de la Rubia J
Article. 10.3109/10428194.2014.922182. 2015
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Cerebral phaeohyphomycosis: Description of a case and review of the literature
Frasquet-Artés JS; (...); López-Hontangas JL
Review. 10.1016/j.riam.2012.12.008. 2014
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus
Berenguer, Juan; (...); Gonzalez-Garcia, Juan
Article. 10.1016/j.jhep.2013.01.042. 2013
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.
Betancor G; (...); Soriano V
Article. 10.1186/1742-4690-9-68. 2012
Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus
Berenguer J; (...); González-García J
Article. 10.1093/cid/ciu939. 2015
Control y prevención de las infecciones nosocomiales y asociadas a cuidados sanitarios causadas por especies de Candida y otras levaduras
Pemán J, Zaragoza R, Salavert M.
Article. 2013
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.
Grau S; (...); Rubio-Terrés C
Article. 10.2147/CEOR.S91587. 2015
Chronic pain and a single lesion in the distal radius
Di Benedetto N; (...); Salavert M
Editorial Material. 10.1016/j.eimc.2014.11.011. 2015
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
Shaw E; (...); Instituto de Salud Carlos III, Madrid, Spain
Article. 10.1136/bmjopen-2014-006723. 2015
Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain
Serrano-Villar, S; (...); CoRIS
Article. 10.1111/jvh.12353. 2015
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Arribas JR; (...); OLE
Article. 10.1016/S1473-3099(15)00096-1. 2015
EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
Article. 10.1038/bmt.2013.190. 2014
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
Rubio-Terrés C; (...); Gani R
Article. 10.1007/s10096-015-2472-0. 2015
ECONOMIC EVALUATION OF FIDAXOMICIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS (CDI) ALSO KNOWN AS CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHOEA (CDAD) IN SPAIN
Cobo Reinoso J; (...); Rubio-Rodriguez D
Meeting Abstract. 10.1016/j.jval.2014.08.2501. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis
Berenguer J; (...); González-García J
Article. 10.1097/QAI.0000000000000156. 2014
Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial
Martinez-Atienza, J; (...); Cordero, E
Article. 10.1186/1745-6215-15-338. 2014
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection
Polo Rodríguez R; (...); Martínez Chamorro E
Article. 10.1016/j.eimc.2014.05.018. 2015
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)
Expert Panel of GeSIDA and the National Aids Plan; (...); Rivero A
Article. 10.1016/j.eimc.2014.02.018. 2014
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015)
Expert Panel of GESIDA and the National AIDS Plan; (...); Rivero A
Article. 10.1016/j.eimc.2015.03.017. 2015
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY
Paz S; (...); Urcelay J
Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015
Feohifomicosis cerebral: Descriptción de un caso y revisión de la literatura
Frasquet-Artés JS; (...); López-Hontangas JL.
Article. 2014
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
Hazardous drugs: new challenges, new opportunities.
Valero García S; (...); Poveda Andrés JL
Article. 10.7399/fh.2016.40.2.10462. 2016
Hematologic neoplasms: interpreting lung findings in chest computed tomography.
Calvillo Batllés P; (...); Compte Torrero L
Article. 10.1016/j.rx.2015.07.003. 2015
How to assist clinicians in improving antimicrobial prescribing: tools and interventions provided by stewardship programs.
López-Medrano F; (...); Salavert M
Article. 10.1016/S0213-005X(13)70131-9. 2013
Human Immunodeficiency Virus Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma
Aguro, F; (...); FIPSE Investigators
Article. 10.1002/hep.28321. 2016
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics.
Berenguer, J; (...); Gonzalez-Garcia, J
Article. 10.1093/ofid/ofw059. 2016
Immunopathogenesis of invasive mould infections
García-Vidal C, Salavert Lletí M
Review. 10.1016/j.riam.2014.09.001. 2014
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis
Montesinos P; (...); Sanz MA
Article. 10.1038/bmt.2015.181. 2015
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.
Bosó V; (...); Aliño SF
Article. 10.1124/dmd.112.047977. 2013
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
Merchante N; (...); Pineda JA
Article. 10.1093/cid/cis777. 2013
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Perez-Romero, P; (...); Influenza Vaccine Solid Organ
Article. 10.1016/j.cmi.2015.07.014. 2015
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Blanes M; (...); de la Rubia J
Article. 10.1016/j.bbmt.2012.08.009. 2013
Invasive fungal disease due to Scedosporium, Fusarium and mucorales
Review. 10.1016/j.riam.2014.05.002. 2014
Invasive infection diseases by filamentous fungi
Ramírez P, Salavert, M, Quindos, G
Editorial Material. 10.1016/j.riam.2014.07.002. 2014
Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice
Crespo J; (...); Calleja JL
Article. 10.1016/j.gastrohep.2015.04.002. 2015
Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.
Mateos MV; (...); San Miguel JF
Article. 10.1056/NEJMoa1300439. 2013
Limbic encephalitis and related cortical syndromes.
Rubio-Agusti I, Salavert M, Bataller L
Article. 10.1007/s11940-012-0212-7. 2013
Lopinavir/ritonavir en pacientes infectados por el virus de la inmunodeficiencia humana en situaciones especiales.
Tasias M, Aldeguer JL
Article. 10.1016/S0213-005X(14)70163-6. 2014
Management of Infection and Febrile Neutropenia in Patients with Solid Cancer
Aguado, JM; (...); Carratala, J
Review. 10.1016/j.eimc.2015.06.005. 2017
Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report.
Roca-Argente L; (...); Hernández-Jaras J
Article. 10.3978/j.issn.2305-5839.2015.10.29. 2015
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.
Santos M; (...); Gobernado M
Article. 10.1155/2014/371370. 2014
N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM
Climente Martí M, Poveda Andrés JL, Culebras J
Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015
Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; (...); Poveda JL
Article. 10.1159/000360691. 2013
PHARMACOECONOMIC ANALYSIS OF ANIDULAFUNGIN, MICAFUNGIN, CASPOFUNGIN AND FLUCONAZOLE IN THE TREATMENT OF CANDIDEMIA AND/OR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULT PATIENTS IN SPAIN
Grau S; (...); Rubio-Terrés C
Meeting Abstract. 10.1016/j.jval.2015.09.1961. 2015
Pleuropulmonary angiosarcoma involving the liver, the jejunum and the spine, developed from chronic tuberculosis pyothorax: Multidisciplinary approach and review of literature
Bruixola G; (...); Aparicio J
Review. 10.1016/j.lungcan.2014.07.012. 2014
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
Megías-Vericat JE; (...); Aliño SF
Letter. 10.1038/tpj.2015.79. 2016
Prevention and control of nosocomial and health-care facilities associated infections caused by species of Candida and other yeasts.
Pemán J, Zaragoza R, Salavert M
Abstract of Published Item. 2013
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort
Meije, Y; (...); Gavalda, J
Article. 10.1111/tid.12226. 2014
Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient
Cavadas, PC; (...); Mayordomo-Aranda, E
Article. 10.1111/ajt.13313. 2015
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Renal Transplantation Recipients with AA Genotype in SNP rs4244285 of CYP2C19 Show An Increase in Hospital Stay Duration and Allograft Dysfunction Probably Due to Increased Tacrolimus Levels Caused by Interaction with Omeprazol
Boso, V; (...); Alino, S. F.
Article. 10.1097/00007890-201211271-01757. 2012
Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study
Hernando, V; (...); CoRIS
Article. 10.1186/1471-2393-14-194. 2014
Role of autologous bone marrow transplant in multiple myeloma.
Article. 10.1097/CCO.0b013e328358f686. 2012
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.
Berenguer J; (...); González-García J
Article. 10.1093/cid/cis500. 2012
Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
Minguez C; (...); Lopez-Aldeguer J
Meeting Abstract. 10.7448/IAS.17.4.19634. 2014
The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
Gonzalez EO; (...); Llerena G
Meeting Abstract. 10.7448/IAS.17.4.19643. 2014
The threat of the carbapenemase-producing enterobacteriaceae in Spain: Positioning report of the SEIMC study groups, GEIH and GEMARA
Oteo J; (...); Salavert M
Article. 10.1016/j.eimc.2014.02.011. 2014
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014
Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment
Montesinos P; (...); Sanz MÁ
Article. 10.1016/j.riam.2014.10.003. 2015
Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy.
Berenguer J; (...); Del Amo J
Article. 10.1097/QAD.0b013e3283574e94. 2012
Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes
Monge, S; (...); Del Amo, J
Article. 10.5588/ijtld.13.0778. 2014
Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial
Torre-Cisneros, J; (...); Aguado, JM
Article. 10.1093/cid/civ156. 2015
Validation of a risk score for post-engraftment invasive fungal disease in 414 adult allogeneic hematopoietic stem cell transplant recipients
Montesinos, P.; (...); Sanz, M. A.
Meeting Abstract. 2016
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
Santos JR; (...); Clotet B
Article. 10.1093/jac/dkv205. 2015
Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review
Tung Chen Y; (...); Salavert M
Letter. 10.1111/1756-185X.12427. 2014